Efficacy and Safety of Sotagliflozin Versus Placebo and Empagliflozin in Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control While Taking a DPP4 Inhibitor Alone or With Metformin

NCT03351478 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

770

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Sotagliflozin
DRUG: Empagliflozin
DRUG: Placebo
DRUG: Placebo

Sponsor

Lexicon Pharmaceuticals

Collaborators

[object Object]